Evidence map›Paper›PMID 32875052›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)2020

Anterolateral entorhinal cortex thickness as a new biomarker for early detection of Alzheimer's disease.

Andrew J Holbrook, Nicholas J Tustison, Freddie Marquez, Jared Roberts, Michael A Yassa, Daniel L Gillen, Alzheimer's Disease Neuroimaging Initiative§

Registry-linked trialAbstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03860857 (The BEACoN Study- Biomarker Exploration in Aging, Cognition and Neurodegeneration), which is not on this map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03860857 phase3recruitingnot on this map

The BEACoN Study- Biomarker Exploration in Aging, Cognition and Neurodegeneration

TypeinterventionalSponsorUniversity of California, IrvineRan2018 to 2027Enrolled300ConditionsAlzheimer Disease, Cognitive Impairment, Cognitive DeclineArmsAmyloid PET scan, Tau PET scan using MK-6240, Neurocognitive testing, MRI
3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Quantification of perforant path fibers for early detection of Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. The Inflammatory GeneBiomedicines · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Andrew J HolbrookDepartment of Biostatistics University of California Los Angeles California USA.
Nicholas J TustisonDepartment of Radiology and Medical Imaging University of Virginia Charlottesville Virginia USA.
Freddie MarquezDepartment of Neurobiology and Behavior and Center for the Neurobiology of Learning and Memory University of California, Irvine Irvine California USA.
Jared RobertsDepartment of Neurobiology and Behavior and Center for the Neurobiology of Learning and Memory University of California, Irvine Irvine California USA.
Michael A YassaDepartment of Neurobiology and Behavior and Center for the Neurobiology of Learning and Memory University of California, Irvine Irvine California USA.
Daniel L GillenDepartment of Statistics University of California Irvine California USA.
Alzheimer's Disease Neuroimaging Initiative§

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
'T V ASSESSMENT - MEMORY DISORDERED PATIENTS'P50AG005146 · NIA · JOHNS HOPKINS UNIVERSITY · PI HUGANIR, RICHARD L · 1985 to 2019
$37.6M
UC Irvine Alzheimer's Disease Research Center Induced Pluripotent Stem Cell CoreP50AG016573 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI LAFERLA, FRANK M · 2000 to 2019
$37.0M
The Alzheimer's Disease Research Center at the University of California, IrvineP30AG066519 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI Crystal M. Glover · 2020 to 2026
$27.9M
Neuroimaging biomarkers for cognitive decline in elderly with amyloid pathologyR01AG053555 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI Michael A Yassa · 2017 to 2026
$17.0M
TR&D 4: Algorithms for functional and anatomical brain analysisP41EB015909 · NIBIB · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI VAN ZIJL, PETER CM · 2012 to 2020
$13.1M
Training in the Neurobiology of Aging and Alzheimers DiseaseT32AG000096 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI VIVEK SWARUP, Craig E Stark · 1985 to 2026
$9.6M
NIA NIH HHS P30 AG066519NIA NIH HHS P50 AG005146NIA NIH HHS P50 AG016573NIA NIH HHS R01 AG053555NIA NIH HHS T32 AG000096NIA NIH HHS U01 AG024904NIBIB NIH HHS P41 EB015909
6 · The paper itself

Abstract

introductionLoss of entorhinal cortex (EC) layer II neurons represents the earliest Alzheimer's disease (AD) lesion in the brain. Research suggests differing functional roles between two EC subregions, the anterolateral EC (aLEC) and the posteromedial EC (pMEC).

methodsWe use joint label fusion to obtain aLEC and pMEC cortical thickness measurements from serial magnetic resonance imaging scans of 775 ADNI-1 participants (219 healthy; 380 mild cognitive impairment; 176 AD) and use linear mixed-effects models to analyze longitudinal associations among cortical thickness, disease status, and cognitive measures.

resultsGroup status is reliably predicted by aLEC thickness, which also exhibits greater associations with cognitive outcomes than does pMEC thickness. Change in aLEC thickness is also associated with cerebrospinal fluid amyloid and tau levels. DISCUSSION: Thinning of aLEC is a sensitive structural biomarker that changes over short durations in the course of AD and tracks disease severity-it is a strong candidate biomarker for detection of early AD.

Indexed as

ADNI‐1Alzheimer's diseaseanterolateral entorhinal cortexbiomarkerbrain imagingcerebrospinal fluid amyloidClinical Dementia Ratingcortical thicknesslinear mixed‐effects modelsmemorymild cognitive impairmentMini‐Mental State Examposteromedial entorhinal cortexreceiver operating characteristic

Identifiers

PMID32875052
PMCPMC7447874

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.